Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2024-518692-56-00Phase 4Authorised
Phase 4, open-label, single-arm trial of diphtheria, tetanus, and acellular pertussis vaccine in pertussis, diphtheria, Tetanus and 1 more, sponsored by University of Antwerp. Planned start Sep 2021; status: authorised.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2024-518692-56-00.